# Laboratorio Reig Jofre S.A.

> Laboratorio Reig Jofre S.A. (BME:RJF) announcements published on FAQSIR. AI-generated content. Paid-for issuer communication. Not investment advice.

canonical: https://faqsir.com/company/laboratorio-reig-jofre-sa
generated_at: 2026-10-21T09:49:51+00:00

## Company

- Name: Laboratorio Reig Jofre S.A.
- Listings: BME:RJF
- Also known as: REIG JOFRE, Reig Jofre, Laboratorio Reig Jofre, Laboratorios Reig Jofre
- Website: https://reigjofre.com/en/

## Disclosure

- AI-generated content: This article was generated by an artificial intelligence system from an announcement published by the issuer. It has not been independently researched, verified, or edited by a journalist, and no person holds editorial responsibility for its wording.
- Unpaid evaluation: The issuer named in this article has not paid for this page and has no commercial relationship with its publisher. This is an unpaid evaluation preview produced from announcements the issuer published publicly, and it is not independent editorial coverage.
- Not investment advice: This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.
- Grounding: Content is generated from the company's published announcements.
- Disclosure version: 2026.09.3

## Endpoints

- [Company hub](https://faqsir.com/company/laboratorio-reig-jofre-sa): the Laboratorio Reig Jofre S.A. announcements listed below, as a page
- [Latest announcement](https://faqsir.com/company/laboratorio-reig-jofre-sa/latest): redirects to the newest release, or to the hub when there is no recent one
- [Atom feed](https://faqsir.com/company/laboratorio-reig-jofre-sa/feed): the latest 50 releases, as Atom
- [JSON feed](https://faqsir.com/company/laboratorio-reig-jofre-sa/feed.json): the latest 50 releases, as JSON Feed 1.1
- [Site-wide llms.txt](https://faqsir.com/llms.txt): what this site publishes beyond this issuer

## Releases

Every announcement this hub lists: 7 announcements, newest first. Each URL is that release's canonical URL.

- 2026-07-31 — [REIG JOFRE reports €17.9 million EBITDA for H1 2026 as Toledo antibiotics line starts production](https://faqsir.com/company/laboratorio-reig-jofre-sa/reig-jofre-reports-eur179-million-ebitda-for-h1-2026-as-toledo-antibiotics-line-starts-production): REIG JOFRE reported higher EBITDA and net income in H1 2026, while its new penicillin-based injectable antibiotics line in Toledo received regulatory approval and began production.
- 2026-06-10 — [REIG JOFRE begins European marketing of dalbavancin across nine countries](https://faqsir.com/company/laboratorio-reig-jofre-sa/reig-jofre-begins-european-marketing-of-dalbavancin-across-nine-countries): REIG JOFRE has added dalbavancin to its hospital anti-infectives portfolio, with the injectable antibiotic available across nine European countries.
- 2026-05-27 — [REIG JOFRE Receives Recognition for VINCOBIOSIS® at Aesthetic Technology Awards](https://faqsir.com/company/laboratorio-reig-jofre-sa/reig-jofre-receives-recognition-for-vincobiosis-at-aesthetic-technology-awards): REIG JOFRE has received recognition at the 2nd Aesthetic Technology Awards for VINCOBIOSIS® and its contribution to scientific progress in health and aesthetics.
- 2026-05-07 — [REIG JOFRE reports Q1 2026 revenue decrease as EBITDA rises 1%](https://faqsir.com/company/laboratorio-reig-jofre-sa/reig-jofre-reports-q1-2026-revenue-decrease-as-ebitda-rises-1): REIG JOFRE reported €86 million in Q1 2026 revenue, a decrease of 2% compared with Q1 2025, alongside consolidated EBITDA of €10 million.
- 2026-02-27 — [REIG JOFRE reports €331.1M revenue for 2025 as Toledo upgrades weigh on antibiotics](https://faqsir.com/company/laboratorio-reig-jofre-sa/reig-jofre-reports-eur3311m-revenue-for-2025-as-toledo-upgrades-weigh-on-antibiotics): REIG JOFRE reported €331.1M in 2025 revenue, while upgrades to two Toledo production lines contributed to a 30% decline in its antibiotics business.
- 2025-12-02 — [REIG JOFRE announces increase in Leanbio stake to 85% for 3.5 million euros](https://faqsir.com/company/laboratorio-reig-jofre-sa/reig-jofre-announces-increase-in-leanbio-stake-to-85-for-35-million-euros): REIG JOFRE has announced that it increased its stake in Barcelona-based biotechnology company Leanbio from 47% to 85% through a 3.5 million euro acquisition from existing shareholders.
- 2025-11-05 — [REIG JOFRE reports €242 million revenue for first nine months of 2025](https://faqsir.com/company/laboratorio-reig-jofre-sa/reig-jofre-reports-eur242-million-revenue-for-first-nine-months-of-2025): REIG JOFRE reported €242 million in revenue for the first nine months of 2025 as temporary lower antibiotic production affected results during industrial upgrades in Toledo and Barcelona.